Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Wagner

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Molecular Cancer Research : MCR|June 8, 2022
Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose MetabolismBhopal C Mohapatra, Sameer Mirza, Aditya Bele, et al.
Journal of the National Cancer Institute|August 3, 2006
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECOJacobus Pfisterer, Béatrice Weber, Alexander Reuss, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2017
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG StudySandro Pignata, Giovanni Scambia, Alessandra Bologna, et al.
Communications Biology|February 16, 2022
Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol effluxIdit Dotan, Jiaqi Yang, Jiro Ikeda, et al.
Geburtshilfe Und Frauenheilkunde|August 16, 2021
Caesarean Section. Guideline of the DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/084, June 2020)Frank Louwen, Uwe Wagner, Michael Abou-Dakn, et al.
Circulation Research|September 12, 2024
Myeloid-Specific JAK2 Contributes to Inflammation and Salt Sensitivity of Blood PressureMohammad Saleem, Luul A Aden, Ashley L Mutchler, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Molecular Cancer Research : MCR|June 8, 2022
Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose MetabolismBhopal C Mohapatra, Sameer Mirza, Aditya Bele, et al.
Journal of the National Cancer Institute|August 3, 2006
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECOJacobus Pfisterer, Béatrice Weber, Alexander Reuss, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2017
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG StudySandro Pignata, Giovanni Scambia, Alessandra Bologna, et al.
Communications Biology|February 16, 2022
Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol effluxIdit Dotan, Jiaqi Yang, Jiro Ikeda, et al.
Geburtshilfe Und Frauenheilkunde|August 16, 2021
Caesarean Section. Guideline of the DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/084, June 2020)Frank Louwen, Uwe Wagner, Michael Abou-Dakn, et al.
Circulation Research|September 12, 2024
Myeloid-Specific JAK2 Contributes to Inflammation and Salt Sensitivity of Blood PressureMohammad Saleem, Luul A Aden, Ashley L Mutchler, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 21